Immuron Approved to Commence Clinical Study in C.Difficile Infection (CDI)
Immuron Limited - American Depositary Shares (IMRN)
US:NASDAQ Investor Relations:
immuron.com/investor-centre/business-overview
Company Research
Source: GlobeNewswire
Key Highlights Final approval for key first in-human Clinical Study for CDI treatment, by Israeli Ministry of HealthAn estimated 28,000 patients die each year from CDI infections in the USA aloneStudy of 60 CDI patients to commence at Jerusalem’s Hadassah Medical Centre in Sept 2017Study designed to demonstrate Safety, Tolerability and Preliminary Efficacy of IMM-529IMM-529 shows effectiveness against a range of clinically relevant C. difficle bacteria strains Top line results from the clinical trial expected in Q4 2018 MELBOURNE, Australia, Aug. 09, 2017 (GLOBE NEWSWIRE) -- Australian microbiome biopharmaceutical company Immuron Limited (ASX:IMC) (NASDQ:IMRN) today announced it has been granted final approval to commence its first in-human, IMM-529 clinical study for the treatment of Clostridium Difficile Infection (CDI). Approval was received from both the Hadassah Medical Center Ethics Committee, as well as the Israeli Ministry of Health's (MoH) office. Immuron's CDI clinical
Show less
Read more
Impact Snapshot
Event Time:
IMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMRN alerts
High impacting Immuron Limited - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
IMRN
News
- Immuron to host Live Virtual Event [Yahoo! Finance]Yahoo! Finance
- Immuron to host Live Virtual EventGlobeNewswire
- Immuron Travelan® sales continued strong growthGlobeNewswire
- We're Not Very Worried About Immuron's (ASX:IMC) Cash Burn Rate [Yahoo! Finance]Yahoo! Finance
- Immuron Presentation Australian Biologics Festival 2024GlobeNewswire
IMRN
Sec Filings
- 4/23/24 - Form 6-K
- 4/15/24 - Form 6-K
- 4/10/24 - Form 6-K
- IMRN's page on the SEC website